Ghent University Academic Bibliography

Your filters: cql: keyword exact "Breast neoplasms"

Add to list
- Journal Article
- A1
- open access
Hypofractionated radiotherapy in the real-world setting : an international ESTRO- GIRO survey

D. Rodin, B. Tawk, O. Mohamad, S. Grover, F.Y. Moraes, M.L. Yap, E. Zubizarreta and Yolande Lievens (UGent)

(2021) RADIOTHERAPY AND ONCOLOGY. 157. p.32-39
Add to list
- Journal Article
- A1
- open access
Coverage determinants of breast cancer screening in Flanders : an evaluation of the past decade

L. Ding, Svetlana Jidkova (UGent) , M. J. W. Greuter, Koen Van Herck (UGent) , M. Goossens, P. Martens, G. H. de Bock and G. Van Hal

(2020) INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH. 19(1).
Add to list
- Journal Article
- A1
- open access
Human papillomavirus prevalence and breast carcinogenesis : a systematic review and meta-analysis of published literature

Kasper Favere (UGent) , Sonia Menon (UGent) , Kristi Valentine (UGent) , J. Bogers and Davy Vanden Broeck (UGent)

(2018) EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. 39(2). p.161-173
Add to list
Different menopausal hormone regimens and risk of breast cancer

Nele Brusselaers (UGent) , RM Tamimi, P Konings, B Rosner, HO Adami and J Lagergren

(2018) ANNALS OF ONCOLOGY. 29(8). p.1771-1776
Add to list
Physical activity levels after treatment for breast cancer : two-year follow-up

An De Groef, Inge Geraerts, Heleen Demeyer (UGent) , Elien Van der Gucht, Lore Dams, Carlijn de Kinkelder, Sanne Dukers-van Althuis, Marijke Van Kampen and Nele Devoogdt

(2018) BREAST. 40. p.23-28
Add to list
- Journal Article
- A1
- open access
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up : a Dutch randomized controlled multicentre trial (BOOG 2013-08)

LM van Roozendaal, MLG Vane, T van Dalen, JA van der Hage, LJA Strobbe, LJ Boersma, SC Linn, MBI Lobbes, PMP Poortmans, VCG Tjan-Heijnen, et al.

(2017) BMC CANCER. 17.
Add to list
- Journal Article
- A1
Pain characteristics as important contributing factors to upper limb dysfunctions in breast cancer survivors at long term

An De Groef, Mira Meeus (UGent) , Tessa De Vrieze, Lore Vos, Marijke Van Kampen, Marie-Rose Christiaens, Patrick Nevens, Inge Geraerts and Nele Devoogdt

(2017) MUSCULOSKELETAL SCIENCE AND PRACTICE. 29. p.52-59
Add to list
Menopausal hormone therapy and cancer risk : an overestimated risk?

Johanna Simin, Rulla Tamimi, Jesper Lagergren, Hans-Olov Adami and Nele Brusselaers (UGent)

(2017) EUROPEAN JOURNAL OF CANCER. 84. p.60-68
Add to list
- Journal Article
- A1
- open access
Breast cancer risk is increased in the years following false-positive breast cancer screening

Mathijs C Goossens, Isabel De Brabander, Jacques De Greve, Evelien Vaes, Chantal Van Ongeval, Koen Van Herck (UGent) and Eliane Kellen

(2017) EUROPEAN JOURNAL OF CANCER PREVENTION. 26(5). p.396-403
Add to list
Improving systemic breast cancer therapy : time to look beyond the primary tumour?

Eef Vandendriessche (UGent) , G. Van de Putte, Rudy Van den Broecke (UGent) and E. T. M. De Jonge

(2015) FACTS VIEWS AND VISION IN OBGYN. 7(4). p.251-256

Academic Bibliography

Hypofractionated radiotherapy in the real-world setting : an international ESTRO- GIRO survey

Coverage determinants of breast cancer screening in Flanders : an evaluation of the past decade

Human papillomavirus prevalence and breast carcinogenesis : a systematic review and meta-analysis of published literature

Different menopausal hormone regimens and risk of breast cancer

Physical activity levels after treatment for breast cancer : two-year follow-up

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up : a Dutch randomized controlled multicentre trial (BOOG 2013-08)

Pain characteristics as important contributing factors to upper limb dysfunctions in breast cancer survivors at long term

Menopausal hormone therapy and cancer risk : an overestimated risk?

Breast cancer risk is increased in the years following false-positive breast cancer screening

Improving systemic breast cancer therapy : time to look beyond the primary tumour?

Contents

Support

Contact